Limited imaging infrastructure drives MRI growth in India

The country accounted for 22% of the Asia–Pacific MRI market in 2025.

India’s magnetic resonance imaging (MRI) market is projected to grow at a 12% compound annual growth rate (CAGR) between 2026 and 2036, according to GlobalData.

Growth is driven by high demand for advanced diagnostics, a large population, and limited access to high-end imaging infrastructure.

The country accounted for 22% of the Asia–Pacific MRI market in 2025.

US-based Hyperfine has received regulatory approval from India’s Central Drugs Standard Control Organization (CDSCO) for its Swoop portable MRI system, with commercial rollout expected in early 2026.

Swoop is the first US FDA-cleared AI-powered portable MRI designed for brain imaging and will be launched in India through a partnership with medical device distributor Radiosurgery Global (RSG).

Nidhi Bharti, medical devices analyst at GlobalData, said portable MRI systems will change where and when imaging is performed.

She said newer MRI systems bring imaging closer to the point of care, speed up clinical decisions, reduce patient transfers, and improve care coordination.

The Hyperfine-RSG partnership aims to deploy mobile MRI systems in hospitals and care centers where conventional MRIs are not feasible, expanding access to advanced neuroimaging across India.

“As portable MRI systems gain wider adoption in India, they are expected to reduce missed diagnoses and deliver results faster, helping patients move through treatment more smoothly,” said Bharti.